Determining Exercise Tolerance using an EMG Cycle Test in patients with a neuromuscular disorder

Completed

• Conditions: muscle diseases; neuromuscular disorders; 10028396

• Registration Number: NL-OMON48098
• Lead Sponsor: Radboud Universitair Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 90

Inclusion Criteria

- aged 18 years and older
- being able to read and understand the Dutch language
- mentally competent
- being able to cycle at least 8 minutes on a cycle leg and/ or arm ergometer

Exclusion Criteria

- pregnancy
- cognitive impairment
- disabling co-morbidity interfering with the cycle test
- contraindications to Exercise Stress Testing according to the guidelines of the American Heart Association

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>sEMG amplitude<br /><br>sEMG median frequency</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>3D movement analysis<br /><br>spirometry (VO2 max, heart rate, anaerobic threshold, workolad, serum lactate<br /><br>levels, Borg scale)<br /><br>Muscle strength</p><br>